Cingulate Announces Publication of Phase 3 ADHD Trial Results in Journal of Child and Adolescent Psychopharmacology

Data ReadoutpositiveCTx-1301Positive

AI Analysis

Summary

Cingulate announced publication of Phase 3 ADHD trial results for CTx-1301 in the Journal of Child and Adolescent Psychopharmacology, establishing the drug's efficacy and safety profile and validating the company's Precision Timed Release platform technology.

Clinical Trial Data

Phase

Phase 3

Primary Endpoint

Met

Outcome Details

Phase 3 ADHD trial results published demonstrating efficacy and safety profile of CTx-1301

Importance:6/10

Sentiment:

0.60

ADHDPhase 3PublicationEfficacySafetyPrecision Timed Release

Related Companies

$CINGW

Read the original article

Published by GlobeNewswire Clinical Studies on July 30, 2026 12:30 PM

Read Original